Glucose Tolerance in Women Receiving an Ovulatory Suppressant
- 1 July 1964
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 13 (4) , 378-382
- https://doi.org/10.2337/diab.13.4.378
Abstract
A high percentage of women receiving 5 mg of norethynodrel with mestranol in cyclic fashion for contraception have decreased glucose tolerance. Ten per cent have elevated fasting levels, 20% have elevated 1-hour levels and 46% have elevated 2-hour levels (greater than our normal mean + 2 standard deviations of 105, 156 and 113 mg/100 ml, respectively). The incidence of abnormal glucose tolerance is greater in women with a family history of diabetes than in those without a history. It seems reasonable to associate the change in glucose tolerance with the "pseudo-pregnancy" produced by the drug. Many women who have decreased glucose tolerance during natural pregnancy later become permanently diabetic. If this is true of those women with decreased glucose during drug treatment, then this response may identify the prediabetic.Keywords
This publication has 6 references indexed in Scilit:
- Amelioration of Cortisone-Induced Pituitary-Adrenal Suppression by Estrad1Journal of Clinical Endocrinology & Metabolism, 1964
- Potentiation of the Biologic Effect of Administered Cortisol by Estrogen TreatmentJournal of Clinical Endocrinology & Metabolism, 1963
- Inherent Estrogenicity of Norethindrone and Norethynodrel: Comparison with Other Synthetic Progestins and Progesterone1Journal of Clinical Endocrinology & Metabolism, 1962
- EFFECT OF TWO SYNTHETIC ESTROGENS ON THE LEVEL OF SERUM PROTEIN-BOUND IODINE IN MEN AND WOMEN WITH ATHEROSCLEROTIC HEART DISEASEJournal of Clinical Endocrinology & Metabolism, 1961
- PREGNANCY AND THE PREDIABETIC STATEAnnals of the New York Academy of Sciences, 1959
- Carbohydrate Metabolism in Normal PregnancyNew England Journal of Medicine, 1946